Haemophilia

Cover image for Vol. 19 Issue 5

September 2013

Volume 19, Issue 5

Pages 643–798, e270–e323

  1. Commemorative Article

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
    1. You have free access to this content
  2. Review Articles

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
  3. Original Articles

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
    1. Clinical haemophilia

      Establishing a harmonized haemophilia registry for countries with developing health care systems (pages 668–673)

      A. Alzoebie, M. Belhani, P. Eshghi, A. O. Kupesiz, M. Ozelo, M. T. Pompa, J. Potgieter and M. Smith

      Version of Record online: 17 APR 2013 | DOI: 10.1111/hae.12147

    2. Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B (pages 674–678)

      T. Lissitchkov, M. Matysiak, K. Zavilska, P. Laguna, L. Gercheva, A. Antonov, A. Moret, P. Caunedo, J. A. Aznar, M. K. Woodward and A. Páez

      Version of Record online: 7 MAY 2013 | DOI: 10.1111/hae.12148

    3. Inhibitors in haemophilia B: the Italian experience (pages 686–690)

      G. Castaman, E. Bonetti, M. Messina, M. Morfini, A. Rocino, F. A. Scaraggi, G. Tagariello and Italian Association of Hemophilia Centers

      Version of Record online: 22 APR 2013 | DOI: 10.1111/hae.12158

    4. Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy (pages 691–697)

      S. R. Lentz, M. Misgav, M. Ozelo, S. Z. Šalek, D. Veljkovic, M. Recht, M. Cerqueira, A. Tiede, B. Brand, M. E. Mancuso, S. Seremetis, A. Lindblom and U. Martinowitz

      Version of Record online: 7 MAY 2013 | DOI: 10.1111/hae.12159

    5. Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics (pages 698–705)

      R. Kulkarni, F. A. Karim, S. Glamocanin, D. Janic, V. Vdovin, M. Ozelo, L. Rageliene, E. Carboni, P. Laguna, G. Dobaczewski, S. Seremetis, A. Lindblom and E. Santagostino

      Version of Record online: 8 MAY 2013 | DOI: 10.1111/hae.12165

    6. Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A (pages 706–710)

      H. Pergantou, I. Varela, O. Moraloglou, M. Economou, K. Spanou, Z. Kapsimali, N. Constantinidou and H. Platokouki

      Version of Record online: 22 APR 2013 | DOI: 10.1111/hae.12168

    7. Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A (pages 720–726)

      D. Nance, S. N. Fletcher, D. C. Bolgiano, A. R. Thompson, N. C. Josephson and B. A. Konkle

      Version of Record online: 28 MAY 2013 | DOI: 10.1111/hae.12173

    8. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study (pages 736–743)

      A. Gringeri, C. Leissinger, P. A. Cortesi, H. Jo, F. Fusco, S. Riva, B. Antmen, E. Berntorp, C. Biasoli, S. Carpenter, K. Kavakli, M. Morfini, C. Négrier, A. Rocino, W. Schramm, J. Windyga, B. Zülfikar and L. G. Mantovani

      Version of Record online: 3 JUN 2013 | DOI: 10.1111/hae.12178

    9. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters (pages 744–752)

      A. Tuinenburg, S. Biere-Rafi, M. Peters, P. Verhamme, K. Peerlinck, M. J. H. A. Kruip, B. A. P. Laros-Van Gorkom, M. Roest, J. C. M. Meijers, P. W. Kamphuisen and R. E. G. Schutgens

      Version of Record online: 10 MAY 2013 | DOI: 10.1111/hae.12182

    10. von Willebrand factor

    11. Rare bleeding disorders

      Use of global assays to understand clinical phenotype in congenital factor VII deficiency (pages 765–772)

      L. A. Greene, N. A. Goldenberg, M. L. Simpson, E. Villalobos-Menuey, C. Bombardier, S. S. Acharya, P. J. Santiago-Borrero, A. Cambara and D. M. DiMichele

      Version of Record online: 20 MAY 2013 | DOI: 10.1111/hae.12160

    12. Genetics

    13. Laboratory issues

    14. Musculoskeletal

    15. Quality of life

      Impact of personality and depression on quality of life in patients with severe haemophilia in Korea (pages e270–e275)

      S.-Y. Kim, S.-W. Kim, J.-M. Kim, I.-S. Shin, H.-J. Baek, H.-S. Lee, T.-J. Hwang and J.-S. Yoon

      Version of Record online: 28 JUN 2013 | DOI: 10.1111/hae.12221

    16. Women with inherited bleeding disorders

    17. Clinical haemophilia

  4. Letters to the editors

    1. Top of page
    2. Commemorative Article
    3. Review Articles
    4. Original Articles
    5. Letters to the editors
    1. Two novel mutations in the prothrombin gene identified in a patient with compound heterozygous type 1/2 prothrombin deficiency (pages e304–e306)

      P. H. M. Kuijper, M. W. M. Schellings, D. van de Kerkhof, G. A. F. Nicolaes, P. Reitsma, F. Halbertsma and N. Dors

      Version of Record online: 28 MAY 2013 | DOI: 10.1111/hae.12180

    2. Vitamin D deficiency in patients with haemophilia: an underestimated commorbidity (pages e308–e310)

      P. Anagnostis, S. Vakalopoulou, M. Charizopoulou, S. Karras and V. Garipidou

      Version of Record online: 28 MAY 2013 | DOI: 10.1111/hae.12187

    3. Quality of life in paediatric haemophilia A patients (pages e320–e323)

      V. K. Williams, G. Antoniou, A. Jackson and A. Atkins

      Version of Record online: 28 JUN 2013 | DOI: 10.1111/hae.12226

SEARCH

SEARCH BY CITATION